Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Clomiphene in Unexplained Infertility
NCT03681197Phase 1Unknown
- Start
- Jun 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in Unexplained infertility (2 arms). Primary endpoint: Clinical pregnancy rate at 28 days. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on NCT03681197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03681197.